EFFICACY OF BARICITINIB IN PATIENTS TREATED WITH CORTICOSTEROIDS FOR SEVERE COVID-19 PNEUMONIA: A RETROSPECTIVE OBSERVATIONAL COHORT STUDY

INTRO: Current evidence is still lacking in use of baricitinib among COVID-19 patients that require low flow oxygen and have systemic inflammation. Therefore, we are keen to evaluate the efficacy of baricitinib therapy among this group of patients, in preventing progression into high flow oxygen dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Tay, K.H., Sim, L.H. Benedict, Chidambaram, S.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186886/
http://dx.doi.org/10.1016/j.ijid.2023.04.239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186886/
http://dx.doi.org/10.1016/j.ijid.2023.04.239

Ejemplares similares